[After-hours Analysis of U.S. Stocks] The members of the Federal Reserve Board changed, and U.S. stocks fluctuated! (2025.08.08)
Apple announced that it would invest hundreds of billions of dollars to circumvent tariffs, and Trump also released policies that helped drive technology stocks higher. However, the market remained on the sidelines of the SPC personnel rumors, and U.S. stocks closed flat at the end. Information technology stocks led the gains, while the financial and medical sectors were weak.
Market analysis
Quick view of financial report
Lilly raises full-year financial forecast, Mounjaro and Zepbound sales surge, but oral weight loss drug data eclipse
Lilly's second-quarter results were significantly better than expected. Thanks to the explosion in sales of diabetes drug Mounjaro and weight-loss drug Zepbound, the company raised its 2025 revenue forecast to US$60 billion to US$62 billion, and its EPS forecast rose to US$21.75 to US$23. However, late trial data of oral weight loss drug orforglipron fell short of market expectations, causing the stock price to plummet by more than 10%. Despite competition from Novo Nordisk (NOVO-B.CO) and pressure from the U.S. government to lower drug prices, Lilly's market share in the GLP-1 market has reached 57%, and is expected to continue to lead.
Core drug sales exceed expectations
第二季 Mounjaro 销售 52 亿美元,年增 68%,高于市场预估的 44.9 亿美元;Zepbound 销售 33.8 亿美元,年增 172%,同样超过预期的 30.6 亿美元。Financial forecast upward shows confidence
全年营收预测由 580 亿至 610 亿美元上调至 600 亿至 620 亿美元;EPS 升至 21.75 至 23 美元,反映核心业务强劲增长动能。Oral drug data drags down stock prices
Orforglipron 72 周平均减重 12.4%,不及诺和诺德 Wegovy 的 14.9%,引发市场失望,股价早盘跌至 671.54 美元。GLP-1 market share expands
美国 incretin 类药物市占率达 57%,Zepbound 与 Wegovy 周处方数分别为 418,597 与 281,725,显示竞争优势扩大。Policy and competitive pressures coexist
面临美国关税与药价下调政策,以及诺和诺德与仿制药竞争,但 CEO 表示管线充足,未来有望推出更多重磅产品。
major news item closely
general manager Daryl
The United States imposes tariffs on many countries to a century-old high. Although Trump takes negotiating advantages, he still faces economic and legal challenges.
Since taking office, U.S. President Trump has significantly increased import tariffs, pushing the effective tariff rate from 2.5% to about 17%-19%. It is expected to approach 20%, a century high. He has also reached a framework agreement with the European Union, Japan, the United Kingdom, South Korea, Vietnam, Indonesia, Pakistan and the Philippines, covering about 40% of trade volume. However, India and Brazil were imposed a high 50% tariff due to policy differences, while China temporarily enjoyed a 30% tariff until August 12. Although the U.S. trade deficit has narrowed and global retaliatory tariffs have been limited, uncertainties remain about the implementation of commitments, the impact of inflation, and the legitimacy of tariffs.
Tariff policy rises sharply
上任初期美国有效关税率仅约 2.5%,目前已升至 17%-19%,部分国家如印度、巴西面临 50% 关税,中国暂为 30%。Negotiation results and coverage
已与八国达成 10%-20% 关税框架协议,若加上中国,涵盖美国近 54% 贸易流量,惟部分承诺缺乏明确执行机制。mixed economic data
6 月贸易逆差缩小 16%,对中逆差创 21 年新低,但部分就业、通膨与需求数据显示关税已开始产生负面影响。Uncertainty in investment and procurement commitments
日本承诺投资 5,500 亿美元、欧盟 6,000 亿美元,但多依赖民间自愿执行,且缺乏强制约束力。Legal and policy risks
川普援引 1977 年《国际紧急经济权力法》单边加税,已遭上诉法院质疑,结果可能进入最高法院审理,影响政策持续性。
Trump nominated Stephen Miran to serve as a temporary Fed governor, advocating strengthening the president's control over the central bank
U.S. President Trump announced the nomination of Stephen Miran, Chairman of the White House Council of Economic Advisers, to serve as a temporary governor of the Federal Reserve to fill the vacancy left by former governor Kugler's resignation for a term until January 31, 2026. Milan has long advocated shortening the term of governors, allowing the president to replace members at any time, placing 12 regional Federal Reserve Banks under the jurisdiction of governors, and including the Federal Reserve budget in congressional approval, with the goal of improving political accountability and policy transparency. The move is seen as a step in Trump's efforts to cut interest rates and restructure central bank governance, but requires Senate approval and only four policy meetings will be left during his term.
Personnel background and political influence
米兰为川普政府经济顾问委员会主席,曾批评美联储「缺乏问责」与「政策同温层」,支持更强总统干预,可能为川普推动宽松货币政策提供助力。Content of reform proposals
建议将理事任期由 14 年缩至 8 年,并明订总统可随时撤换;将地区联储董事会改由州长任命,区分政治属性;扩大全部 12 位地区行长的政策表决权。Impact of institutional change
若落实,将结束自 1930 年代以来的美联储独立架构,并可能引发央行政治化争议,需要国会立法支持。Validation procedures and time pressure
提名需经参议院银行委员会听证与全院表决,国会 9 月 2 日复会后还需处理政府资金法案,留给米兰的行动窗口有限。Monetary policy background
美联储目前将利率维持在 4.25%-4.50%,近期就业数据走弱促使部分决策者倾向 9 月降息,与川普及部分理事的政策主张一致。
stocks
Trump calls on Intel CEO Chen Liwu to resign, questioning his China investment relationship
U.S. President Trump publicly called on Intel (INTC) CEO Chen Liwu to resign immediately, alleging that his extensive investments with China companies have created a high conflict of interest. Reuters disclosed in April this year that Chen Liwu has invested at least US$200 million in more than 600 China technology and manufacturing companies through venture capital funds and holding companies from 2012 to 2024, some of which are linked to the China People's Liberation Army. The move attracted the attention of Congress, especially as Intel undertakes chip manufacturing tasks from the U.S. Department of Defense and receives an $8 billion subsidy from the Chip and Science Act.
The president rarely puts direct pressure
川普称陈立武「高度冲突」,并指唯一解决方案是辞职,为美国总统罕见公开介入大型企业人事。Congress and media questioned
参议员汤姆·科顿致函英特尔董事会,询问陈立武在成为 CEO 前是否充分揭露投资及利益冲突,并关注其前公司楷登电子 (CDNS) 对中国军事院校销售产品案。China's investment network is huge
路透调查发现,陈立武及其创投机构与中国政府基金、国企共同持有至少 20 项投资,部分对象为受美国制裁的中国军工供应商。Intel's response and stock price reaction
英特尔表示,公司与 CEO 致力于维护美国国家安全,并将持续与政府合作;消息公布后股价下跌 3%。Overwhelming business challenges
英特尔近年在制程与 AI 晶片市场落后台积电与辉达 (NVDA),市值跌破 1,000 亿美元,利润率仅为历史高点的一半,战略转型与领导层稳定性正受多重压力考验。
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.